Method of Treating Psoriasis with Anti-IL23 Specific Antibody

• 收藏
• 分享

专利权人:

Janssen Biotech; Inc.

发明人:

Dennis Fitzgerald,Newman Yielding,Jay Siegel

申请号：

US15813767

公开号：

US20180134784A1

申请日:

2017.11.15

申请国别(地区):

US

年份:

2018

代理人:

摘要：

A method of treating psoriasis in a patient previously treated with and determined to be an inadequate responder to an IL-12/23p40 antibody by administering an IL-23 specific antibody, e.g., guselkumab, in a safe and effective amount and the patient achieves PASI75, PASI90, PASI100 or IGA 0 or 1 score as measured 16, 24, 32, 40 and 48 weeks after initial treatment.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/